Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

“So, we need to increase efficiency on the process development side. While automation is one way of doing that, a much more efficient solution is to use in silico process development data to increase ...

As the pharmaceutical industry adapts to new therapies and ... phase-appropriate quality system is one of the greatest hurdles in the drug development process. AI and machine learning are transforming ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

A new artificial intelligence (AI) platform is poised to radically change the way the pharmaceutical industry ... will benefit if 90 percent of drugs in development proved to be safe, effective ...

Pharmaceutical sciences encompass a wide range of disciplines that focus on the discovery, development, and regulation of drugs ... the overall quality of the process. We however cannot guarantee ...

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

The PCT patent further protects InMed's production methods of its novel pharmaceutical drug development candidates utilizing modern biopharmaceutical manufacturing approaches. The international ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with an alcohol) to be locked treasure chests of possibilities. Ubiquitous as ...